For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Caredx Inc (NASDAQ: CDNA) closed at $20.30 in the last session, down -3.93% from day before closing price of $21.13. In other words, the price has decreased by -$3.93 from its previous closing price. On the day, 1.25 million shares were traded.
Ratios:
We take a closer look at CDNA’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.32 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 35.65. For the most recent quarter (mrq), Quick Ratio is recorded 3.72 and its Current Ratio is at 3.94. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on January 15, 2025, Upgraded its rating to Equal Weight and sets its target price to $24 from $28 previously.
On August 28, 2024, Wells Fargo started tracking the stock assigning a Underweight rating and target price of $28.
BTIG Research Upgraded its Neutral to Buy on August 19, 2024, while the target price for the stock was maintained at $40.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 04 ’25 when Novack Jeffrey Adam sold 3,512 shares for $23.30 per share. The transaction valued at 81,829 led to the insider holds 104,677 shares of the business.
Jeffrey Adam Novack bought 3,512 shares of CDNA for $81,900 on Feb 04 ’25. On Dec 04 ’24, another insider, Novack Jeffrey Adam, who serves as the Secretary and General Counsel of the company, sold 1,917 shares for $26.00 each. As a result, the insider received 49,842 and left with 110,237 shares of the company.
Valuation Measures:
As of this moment, Caredx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 19.96. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.37 while its Price-to-Book (P/B) ratio in mrq is 2.94.
Stock Price History:
Over the past 52 weeks, CDNA has reached a high of $34.84, while it has fallen to a 52-week low of $7.42. The 50-Day Moving Average of the stock is -9.76%, while the 200-Day Moving Average is calculated to be -10.55%.
Shares Statistics:
A total of 54.77M shares are outstanding, with a floating share count of 51.92M. Insiders hold about 6.32% of the company’s shares, while institutions hold 101.11% stake in the company.
